Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Other Accumulated Expenses: 2013-2025

Historic Other Accumulated Expenses for Phibro Animal Health (PAHC) over the last 7 years, with Sep 2025 value amounting to $29.5 million.

  • Phibro Animal Health's Other Accumulated Expenses rose 62.32% to $29.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.5 million, marking a year-over-year increase of 62.32%. This contributed to the annual value of $31.2 million for FY2025, which is 78.09% up from last year.
  • Per Phibro Animal Health's latest filing, its Other Accumulated Expenses stood at $29.5 million for Q3 2025, which was down 5.46% from $31.2 million recorded in Q2 2025.
  • Over the past 5 years, Phibro Animal Health's Other Accumulated Expenses peaked at $46.8 million during Q4 2024, and registered a low of $16.5 million during Q1 2021.
  • In the last 3 years, Phibro Animal Health's Other Accumulated Expenses had a median value of $19.6 million in 2023 and averaged $25.6 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first decreased by 15.99% in 2023, then surged by 135.21% in 2025.
  • Phibro Animal Health's Other Accumulated Expenses (Quarterly) stood at $18.4 million in 2021, then rose by 0.69% to $18.5 million in 2022, then climbed by 12.83% to $20.9 million in 2023, then spiked by 124.05% to $46.8 million in 2024, then soared by 62.32% to $29.5 million in 2025.
  • Its Other Accumulated Expenses was $29.5 million in Q3 2025, compared to $31.2 million in Q2 2025 and $41.7 million in Q1 2025.